Advancing precision oncology in breast cancer: the FDA approval of elacestrant and guardant 360CDx: a correspondenceHaleema Qayyum Abbasi, Wechuli Polyne Nafula, Maryyum Adeena et al.|International Journal of Surgery|2023Cited by 13